产品说明
一般描述
Pharmaceutical secondary standards for application in quality control provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards
生化/生理作用
盐酸左西替利嗪是一种非镇静抗组胺药。它是一种组胺H1受体拮抗剂，西替利嗪的活性异构体。左西替利嗪对H1受体具有较高的生物利用度、高亲和力和占据度。
分析说明
These secondary standards offer multi-traceability to the USP, EP and BP primary standards, where they are available.
其他说明
This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis.
附注
To see an example of a Certificate of Analysis for this material enter LRAA6959(changes by product) in the Documents slot below. This is an example certificate only and may not be the lot that you receive.
基本信息
| 经验(实验)分子式 | C21H25ClN2O3·2HCl |
| 分子量 | 461.81 |
| MDL编号 | MFCD07366507 |
产品性质
| 等级 | certified reference material pharmaceutical secondary standard |
| CofA | current certificate can be downloaded |
| 包装 | pkg of 500 mg |
| application(s) | pharmaceutical |
| 药典可追溯性 | traceable to USP 1359969 |
| 储存温度 | 2-8℃ |
| SMILES string | Cl.Cl.OC(=O)COCCN1CCN(CC1)[C@H](c2ccccc2)c3ccc(Cl)cc3 |
| InChI | 1S/C21H25ClN2O3.2ClH/c22-19-8-6-18(7-9-19)21(17-4-2-1-3-5-17)24-12-10-23(11-13-24)14-15-27-16-20(25)26;;/h1-9,21H,10-16H2,(H,25,26);2*1H/t21-;;/m1../s1 |
| InChI key | PGLIUCLTXOYQMV-GHVWMZMZSA-N |
安全信息
| 象形图 |   |
| 警示用语： | Warning |
| 危险声明 | H302 - H400 |
| 预防措施声明 | P264 - P270 - P273 - P301 + P312 - P391 - P501 |
| 危险分类 | Acute Tox. 4 Oral - Aquatic Acute 1 |
| 储存分类代码 | 11 - Combustible Solids |
| WGK | WGK 3 |
| 闪点(F) | Not applicable |
| 闪点(C) | Not applicable |
